logo
‘Big beautiful bill' will exact enormous costs on disabled individuals and their families

‘Big beautiful bill' will exact enormous costs on disabled individuals and their families

The Hill2 days ago

Until my son Julian was born with Down syndrome in 2009, I knew nothing about the ways that disabled Americans depended on programs like Medicaid to provide the kinds of services and supports they need to live full lives in their communities.
As I got more involved in advocating for him, I learned about the troubling history of discrimination that consigned disabled Americans to a life of abuse, neglect and institutionalization. I also learned about courageous individuals who created the disability rights movement that catalyzed the legislation, regulations and Supreme Court cases that changed the lives of millions of Americans with disabilities.
The more I learned, the prouder I became that we lived in a country that invested in people with even the most significant disabilities. It underscores a belief system that investing in everyone's future exemplifies what it means to be American. Had my son been born in the early 1970s like I was, physicians would have encouraged us to institutionalize him, hiding him away from society.
Sen. Robert F. Kennedy (D-N.Y.) visited the infamous Willowbrook State Developmental Center in New York in 1965 and, horrified by the inhumane conditions in which he found its residents living, famously described it as a 'snake pit.' The subsequent lawsuit on behalf of Willowbrook residents accelerated the pace of deinstitutionalization, providing support for people with intellectual and developmental disabilities to live in their communities.
The 1980s ushered in a new era of Medicaid Home and Community-Based Services (HCBS), which allow disabled individuals to receive supports and services in their own homes, living among their families, friends and neighbors — allowing them to be part of the fabric of their communities. People with disabilities would now have freedoms that the rest of us take for granted: to make choices, to be independent and to live life like everyone else.
As the House budget reconciliation bill makes its way through the Senate, the GOP insists that people with disabilities will not be hurt by proposed Medicaid cuts — and, in fact, that the bill does not cut Medicaid but 'strengthens' it. This is patently false. Despite claims that this bill only focuses on 'waste, fraud, and abuse,' the proposed cuts will devastate the nearly 7 million seniors and people with disabilities who receive these services through Medicaid waivers — as well the 700,000 people on waiting lists for these benefits. (The cuts would trigger reductions in Medicare amounting to about $490 billion over 10 years).
In addition to the direct loss of federal funds from the largest cut in Medicaid history, there is a second and even more significant impact of the GOP bill that will further impair states' ability to support disabled Americans. Under the legislation, states would have no choice but to drastically reduce or eliminate Medicaid HCBS. These critical services — personal care assistance, employment supports, transportation, day programs, home modifications and other services — help people with disabilities avoid being placed in institutions.
Without these services, people with disabilities would face a stark choice: have family members leave the workforce to provide them unpaid assistance or be placed in nursing homes, which are significantly more expensive than Medicaid HCBS. Home and Community-Based Services are cost effective because they reduce both the financial and human costs of institutionalization; proposed reductions in Medicaid would also slash funding for nursing homes.
The devil is in the details of this bill. Lowering the federal share of payments to a state for Medicaid services significantly decreases the amount of funding that a state has available. Additionally, proposed limitations on provider taxes (which states levy on providers like hospitals and nursing homes) are more severe in the Senate bill, and new administrative requirements would decimate state Medicaid budgets that are critical for funding disability services. It's a one-two punch: slashing federal funding while making it impossible for states to fill the gap.
Imperfect as our system for supporting people with disabilities is, no other country has one. Supporting Americans like my son to live their lives as independently as possible is what makes this country great. Helping him to be an employee, a customer, a neighbor and a taxpayer requires investment by both state and federal partners. If the GOP budget plan is enacted, however, it will undermine decades of progress and devastate this system.
Cutting short future opportunities for millions of disabled Americans will exact enormous financial costs to individuals and their families. But there are also moral costs. Disabled Americans are our friends, neighbors and family members who contribute to our communities and our lives. It is immoral to leave them behind on a quest to cut taxes for corporations and the wealthiest among us. Congress must take a wiser and more compassionate approach and stop its destruction of our country's social safety net. My son's future — and the futures of disabled Americans — hangs in the balance.
Allison Wohl is the mother of a 15-year-old son with Down syndrome, whose diagnosis shifted her personal and professional focus to advocacy for the full inclusion of people with disabilities in every aspect of life. She has led two national disability advocacy organizations.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Senators launch a weekend of work to meet Trump's deadline for passing his tax and spending cuts
Senators launch a weekend of work to meet Trump's deadline for passing his tax and spending cuts

Chicago Tribune

time34 minutes ago

  • Chicago Tribune

Senators launch a weekend of work to meet Trump's deadline for passing his tax and spending cuts

WASHINGTON — The Senate launched a rare weekend session Saturday as Republicans race to pass President Donald Trump's package of tax breaks, spending cuts and bolstered deportation funds by his July Fourth deadline. Republicans are using their majorities in Congress to push aside Democratic opposition, but they have run into a series of political and policy setbacks. Not all GOP lawmakers are on board with proposals to reduce spending on Medicaid, food stamps and other programs as a way to help cover the cost of extending some $3.8 trillion in Trump tax breaks. The 940-page bill was released shortly before midnight Friday. Senators are expected to grind through the days ahead with procedural vote Saturday to begin considering the legislation, but the timing was uncertain. There would still be a long path ahead, with hours of potentially all-night debate and eventually voting on countless amendments. Senate passage could be days away, and the bill would need to return to the House for a final round of votes before it could reach the White House. Sen. Bernie Moreno, R-Ohio, opened the day's session with an impassioned defense of the package that he said has been misrepresented by its critics. 'Here's what American workers get out of 'One Big Beautiful Bill,' Moreno said as he began outlining the provisions. 'Read it for yourself.' The weekend session could be a make-or-break moment for Trump's party, which has invested much of its political capital on his signature domestic policy plan. Trump is pushing Congress to wrap it up, even as he sometimes gives mixed signals, allowing for more time. At recent events at the White House, including Friday, Trump has admonished the 'grandstanders' among GOP holdouts to fall in line. 'We can get it done,' Trump said in a social media post. 'It will be a wonderful Celebration for our Country.' The legislation is an ambitious but complicated series of GOP priorities. At its core, it would make permanent many of the tax breaks from Trump's first term that would otherwise expire by year's end if Congress fails to act, resulting in a potential tax increase on Americans. The bill would add new breaks, including no taxes on tips, and commit $350 billion to national security, including for Trump's mass deportation agenda. But the spending cuts that Republicans are relying on to offset the lost tax revenues are causing dissent within the GOP ranks. Some lawmakers say the cuts go too far, particularly for people receiving health care through Medicaid. Meanwhile, conservatives, worried about the nation's debt, are pushing for steeper cuts. Sen. Thom Tillis, R-N.C., said he remains concerned about the fundamentals of the package and will not support the procedural motion to begin debate. Sen. Ron Johnson, R-Wis., pushing for deeper cuts, said he needed to see the final legislative text. With the narrow Republicans majorities in the House and Senate, leaders need almost every lawmaker on board to ensure passage. The release of that draft had been delayed as the Senate parliamentarian reviewed the bill to ensure it complied with the chamber's strict 'Byrd Rule,' named for the late Sen. Robert C. Byrd, It largely bars policy matters from inclusion in budget bills unless a provision can get 60 votes to overcome objections. That would be a tall order in a Senate with a 53-47 GOP edge and Democrats unified against Trump's bill. Republicans suffered a series of setbacks after several proposals were determined to be out of compliance by the chief arbiter of the Senate's rules. One plan would have shifted some food stamp costs from the federal government to the states; a second would have gutted the funding structure of the Consumer Financial Protection Bureau. But over the past days, Republicans have quickly revised those proposals and reinstated them. The final text includes a proposal for cuts to a Medicaid provider tax that had run into parliamentary objections and opposition from several senators worried about the fate of rural hospitals. The new version extends the start date for those cuts and establishes a $25 billion fund to aid rural hospitals and providers. Most states impose the provider tax as a way to boost federal Medicaid reimbursements. Some Republicans argue that is a scam and should be abolished. The nonpartisan Congressional Budget Office has said that under the House-passed version of the bill, some 10.9 million more people would go without health care and at least 3 million fewer would qualify for food aid. The CBO has not yet publicly assessed the Senate draft, which proposes steeper reductions. Top income-earners would see about a $12,000 tax cut under the House bill, while the package would cost the poorest Americans $1,600, the CBO said. The Senate included a compromise over the so-called SALT provision, a deduction for state and local taxes that has been a top priority of lawmakers from New York and other high-tax states, but the issue remains unsettled. The current SALT cap is $10,000 a year, and a handful of Republicans wanted to boost it to $40,000 a year. The final draft includes a $40,000 cap, but for five years instead of 10. Many Republican senators say that is still too generous. At least one House GOP holdout, Rep. Nick LaLota of New York, had said that would be insufficient. Senate Democratic leader Chuck Schumer of New York said Republicans dropped the bill 'in the dead of night' and are rushing to finish the bill before the public fully knows what's in it. House Speaker Mike Johnson, who sent his colleagues home for the weekend with plans to be on call to return to Washington, had said they are 'very close' to finishing up. 'We would still like to meet that July Fourth, self-imposed deadline,' said Johnson, R-La. Johnson and Thune have stayed close to the White House, relying on Trump to pressure holdout lawmakers.

Trump pollster warns Senate GOP against deeper Medicaid cuts
Trump pollster warns Senate GOP against deeper Medicaid cuts

Politico

time41 minutes ago

  • Politico

Trump pollster warns Senate GOP against deeper Medicaid cuts

Senate Republicans released updated megabill text late Friday that would make sharp cuts to the Inflation Reduction Act's solar and wind tax credits after a late-stage push by President Donald Trump to crack down further on the incentives. The text would require solar and wind generation projects seeking to qualify for the law's clean electricity production and investment tax credits to be placed in service by the end of 2027 — significantly more restrictive than an earlier proposal by the Senate Finance Committee that tied eligibility to when a project begins construction. The changes came after Trump urged Senate Majority Leader John Thune to crack down on the wind and solar credits and align the measure more closely with reconciliation text, H.R.1, that passed the House, as POLITICO reported earlier on Friday. The changes are likely to put some moderate GOP senators, who have backed a slower schedule for sunsetting those incentives, in a tough position. They'll be forced to choose between rejecting Trump's agenda or allowing the gutting of tax credits that could lead to canceled projects and job losses in their states — something renewable energy advocates are also warning about. 'We are literally going to have not enough electricity because Trump is killing solar. It's that serious,' Sen. Brian Schatz (D-Hawaii) responded on X early Saturday. 'We need a bunch of new power on the grid, and nothing is as available as solar. Everything else takes a while. Meantime, expect shortages and high prices. Stupid.' The revised text would retain the investment and production tax credits for baseload sources, such as nuclear, geothermal, hydropower or energy storage, as proposed in the Finance Committee's earlier proposal. But it would make other significant changes, including extending a tax credit for clean hydrogen production until 2028. The panel's earlier proposal would have eliminated the credit after this year. And despite vocal lobbying by the solar industry, the proposal would maintain an abrupt cut to the tax incentive supporting residential solar power. The committee's earlier proposal would have eliminated that credit six months after the enactment of the bill; now the updated draft proposes repealing it at the end of this year. It would also deny certain wind and solar leasing arrangements from accessing the climate law's clean electricity investment and production tax credits, but, in a notable change, removed earlier language specifically disallowing rooftop solar. And it would move up the timeline for certain rules barring foreign entities of concern from accessing those credits. The bill would move up the termination date for electric vehicle tax credits to Sept. 30, compared to six months after enactment in the earlier Finance text. The credit for EV chargers would extend through June 2026. The new text also provides a bonus incentive for advanced nuclear facilities built in communities with high levels of employment in the nuclear industry. And the bill makes metallurgical coal eligible for the advanced manufacturing production tax credit through 2029. Sam Ricketts, co-founder of S2 Strategies, a clean energy policy consulting group, said the new draft is going to 'screw' ratepayers, kill jobs and undermine U.S. economic competitiveness. 'All just to give fossil fuel executives more profits,' he said. 'Or to own the libs. Insanity.' Josh Siegel contributed to this report.

Texas politicians lead effort to study a psychedelic drug. What is ibogaine?
Texas politicians lead effort to study a psychedelic drug. What is ibogaine?

USA Today

time42 minutes ago

  • USA Today

Texas politicians lead effort to study a psychedelic drug. What is ibogaine?

Ibogaine is illegal in the U.S., but growing evidence shows its promise treating the effects of traumatic brain injury and substance use disorder. A once obscure traditional psychedelic plant from Africa has made headlines recently as Texas pushes for more research and a prominent Republican wrote a vigorous endorsement of its possible use for the treatment of addiction and for veterans experiencing mental health issues. Ibogaine is illegal for use in the United States, but a growing body of evidence has shown its promise treating the effects of traumatic brain injury and substance use disorder. Earlier in June, Texas Gov. Greg Abbott signed legislation to allocate $50 million for clinical trials approved by the Food and Drug Administration to study ibogaine. Texas is set to lead research into the drug's benefits treating mental health issues and addiction as a potential medication. Former Energy Secretary Rick Perry, also a former Texas governor, wrote a June 27 Washington Post op-ed supporting ibogaine research and criticizing the legacy of the war on drugs, started by President Richard Nixon and touted by President Ronald Reagan. Perry said he has 'come to realize just how wrong that narrative was.' 'That fear-based messaging kept us from exploring treatments that could have saved countless lives,' Perry wrote. Perry and a growing number of conservatives have argued ibogaine could be one of those treatments. Here's what to know about the drug. What is ibogaine? Ibogaine derives from the root of the iboga plant native to western-central Africa. It's been used in ceremonial rituals for centuries. It has hallucinogenic properties. The United States outlawed ibogaine in 1967 along with other psychotropic drugs. The Controlled Substances Act of 1970 placed it as a schedule I hallucinogenic drug, along with marijuana. Ibogaine's classification prevented researchers from studying its effects. But unlike other schedule 1 drugs such as heroin, ibogaine has anti-addictive properties. There are risks since ibogaine can delay the body's normal electrical signals that control heart rhythm, which could lead to death. Other countries, such as Mexico, have allowed its use. American veterans and others have traveled to smaller, clandestine clinics for treatment to deal with depression, post-traumatic stress disorder and addiction. Many clinics are along the border and around cities such as Tijuana. Why is it in the news? At the state and federal level, there is growing interest in studying psychedelic drugs to treat veterans and others. Texas passed legislation earlier in June to study the drug with a public university alongside a company and hospital, Abbott's office said. Dr. Marty Makary, the FDA commissioner, has said expanding research on psychedelic drugs is a top priority for the Trump administration. In his op-ed, Perry cited the experiences of Morgan and Marcus Luttrell, twin combat veterans, who used ibogaine for recovery. Morgan Luttrell is now a Republican congressman from Texas who has advocated for ibogaine and other psychedelic drugs as treatment options. In January 2025, Perry and W. Bryan Hubbard, an advocate for ibogaine treatment, appeared on Joe Rogan's podcast to discuss ibogaine's benefits as a plant-based medicine. Hubbard led a Kentucky task force that sought to use opioid settlement funds to research ibogaine's effects to treat addiction, but the initiative failed to gain support in the state. Hubbard and Perry eventually launched the Texas Ibogaine Initiative, which helped spur the state funding. What has research shown? Research, such as a Stanford University study of 30 male combat veterans, has shown ibogaine's promise. Coupled with magnesium sulfate to address heart effects, ibogaine appeared to reduce symptoms of PTSD, anxiety and depression, and improve cognitive function from traumatic brain injury, according to the study, published in 2024 in the eminent journal Nature Medicine. Other studies have shown benefits treating addiction and depression. What do critics say? One issue with ibogaine is the ability to produce it, because it is derived from a rare plant and has mostly been used for ceremonial purposes. There is research to help innovate its safe production, but it could be difficult for the drug to be more widely available, as researchers at the University of California, Davis, Institute for Psychedelics and Neurotherapeutics have said. And while it's shown benefits with combat veterans, questions remain on its efficacy among randomized participants. With Texas' research, ibogaine could get closer to FDA approval for its use as a medication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store